Article ID Journal Published Year Pages File Type
5537079 Vaccine 2017 10 Pages PDF
Abstract
Invasive pneumococcal diseases and pneumonia rates among the adult population decreased in most countries following PCV introduction into the NIP. This indirect effect on older population seems to be dependent on PCV coverage rates and time from PCV nationwide implementation. Adults >65 years old seem to benefit the most from PCV introduction.
Related Topics
Life Sciences Immunology and Microbiology Immunology
Authors
, ,